Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Schöpf-Schulz-Passarge Syndrome: Previously Unreported WNT10A Genotype and Phenotypes in 9 Family Members.

Zimmermann CE, Soufi M, Ruppert V, Schaefer JR, von Domarus H.

Acta Derm Venereol. 2018 Sep 28. doi: 10.2340/00015555-3055. [Epub ahead of print] No abstract available.

2.

Teaching medicine with the help of "Dr. House".

Jerrentrup A, Mueller T, Glowalla U, Herder M, Henrichs N, Neubauer A, Schaefer JR.

PLoS One. 2018 Mar 13;13(3):e0193972. doi: 10.1371/journal.pone.0193972. eCollection 2018.

3.

Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity.

Klaus G, Taylan C, Büscher R, Schmitt CP, Pape L, Oh J, Driemeyer J, Galiano M, König J, Schürfeld C, Spitthöver R, Schaefer JR, Weber LT, Heibges A, Klingel R.

Pediatr Nephrol. 2018 Jul;33(7):1199-1208. doi: 10.1007/s00467-018-3906-6. Epub 2018 Mar 3.

PMID:
29502162
4.

Characteristics of patients contacting a center for undiagnosed and rare diseases.

Mueller T, Jerrentrup A, Bauer MJ, Fritsch HW, Schaefer JR.

Orphanet J Rare Dis. 2016 Jun 21;11(1):81. doi: 10.1186/s13023-016-0467-2.

5.

Better lipid target achievement for secondary prevention through disease management programs for diabetes mellitus and coronary heart disease in clinical practice in Germany.

Gitt AK, Sonntag F, Jannowitz C, Weizel A, Karmann B, Schaefer JR, Pittrow D, Hildemann SK.

Curr Med Res Opin. 2016;32(3):417-26. doi: 10.1185/03007995.2015.1120715. Epub 2015 Dec 29.

PMID:
26568400
6.

Postmortem Examinations for the Etiological Identification of Juvenile Coronary Arteriosclerosis.

Heide S, Lessig R, Diers V, Schaefer JR, Soufi M.

Am J Forensic Med Pathol. 2015 Sep;36(3):149-52. doi: 10.1097/PAF.0000000000000171.

PMID:
26079403
7.

Lipoprotein(a)-clinical aspects and future challenges.

Kurt B, Soufi M, Sattler A, Schaefer JR.

Clin Res Cardiol Suppl. 2015 Apr;10:26-32. doi: 10.1007/s11789-015-0075-z.

8.

[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology].

Klose G, Beil FU, Dieplinger H, von Eckardstein A, Föger B, Gouni-Berthold I, Koenig W, Kostner GM, Landmesser U, Laufs U, Leistikow F, März W, Merkel M, Müller-Wieland D, Noll G, Parhofer KG, Paulweber B, Riesen W, Schaefer JR, Steinhagen-Thiessen E, Steinmetz A, Toplak H, Wanner C, Windler E.

Internist (Berl). 2014 May;55(5):601-6. doi: 10.1007/s00108-014-3492-z. German. Erratum in: Internist (Berl). 2014 Sep;55(9):1112.

PMID:
24770979
9.

New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk.

Klose G, Beil FU, Dieplinger H, von Eckardstein A, Föger B, Gouni-Berthold I, Heigl F, Koenig W, Kostner GM, Landmesser U, Laufs U, Leistikow F, März W, Noll G, Parhofer KG, Paulweber B, Riesen WF, Schaefer JR, Steinhagen-Thiessen E, Steinmetz A, Toplak H, Wanner C, Windler E; American Heart Association, American College of Cardiology.

Wien Klin Wochenschr. 2014 Mar;126(5-6):169-75. doi: 10.1007/s00508-014-0513-9. Epub 2014 Mar 11.

PMID:
24615676
10.

Improved detection of paroxysmal atrial fibrillation utilizing a software-assisted electrocardiogram approach.

Schaefer JR, Leussler D, Rosin L, Pittrow D, Hepp T.

PLoS One. 2014 Feb 28;9(2):e89328. doi: 10.1371/journal.pone.0089328. eCollection 2014.

11.

Cobalt intoxication diagnosed with the help of Dr House.

Dahms K, Sharkova Y, Heitland P, Pankuweit S, Schaefer JR.

Lancet. 2014 Feb 8;383(9916):574. doi: 10.1016/S0140-6736(14)60037-4. No abstract available.

PMID:
24506908
12.

A combined LDL receptor/LDL receptor adaptor protein 1 mutation as the cause for severe familial hypercholesterolemia.

Soufi M, Rust S, Walter M, Schaefer JR.

Gene. 2013 May 25;521(1):200-3. doi: 10.1016/j.gene.2013.03.034. Epub 2013 Mar 17.

PMID:
23510778
13.

Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry.

Schaefer JR, Gitt AK, Sonntag F, Weizel A, Jannowitz C, Karmann B, Pittrow D, Bestehorn K.

Vasc Health Risk Manag. 2013;9:71-80. doi: 10.2147/VHRM.S37143. Epub 2013 Feb 21.

14.

In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a).

Frischmann ME, Ikewaki K, Trenkwalder E, Lamina C, Dieplinger B, Soufi M, Schweer H, Schaefer JR, König P, Kronenberg F, Dieplinger H.

Atherosclerosis. 2012 Dec;225(2):322-7. doi: 10.1016/j.atherosclerosis.2012.09.031. Epub 2012 Oct 5.

PMID:
23099120
15.

[Lipid therapy in daily routine].

Sonntag F, Schaefer JR, Gitt AK, Weizel A, Jannowitz C, Karmann B, Pittrow D, Bestehorn K.

Dtsch Med Wochenschr. 2012 Oct;137(40):2047-52. Epub 2012 Sep 28. Review. German.

PMID:
23023622
16.

Mutation screening of the APOA5 gene in subjects with coronary artery disease.

Soufi M, Sattler AM, Kurt B, Schaefer JR.

J Investig Med. 2012 Oct;60(7):1015-9. doi: 10.2310/JIM.0b013e3182686918.

PMID:
22914599
17.

Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R).

Schaefer JR, Kurt B, Sattler A, Klaus G, Soufi M.

Clin Res Cardiol Suppl. 2012 Jun;7:2-6.

18.

The impact of severe LDL receptor mutations on SREBP-pathway regulation in homozygous familial hypercholesterolemia (FH).

Soufi M, Ruppert V, Kurt B, Schaefer JR.

Gene. 2012 May 10;499(1):218-22. doi: 10.1016/j.gene.2012.02.031. Epub 2012 Mar 9.

PMID:
22425645
19.

[HDL level or HDL function as the primary target in preventive cardiology].

Schaefer JR.

Herz. 2012 Feb;37(1):51-5. doi: 10.1007/s00059-011-3563-z. Review. German.

PMID:
22258137
20.

Identification of a gene variant in the master regulator of lipid metabolism SREBP-1 in a family with a novel form of severe combined hypolipidemia.

Kotzka J, Knebel B, Janssen OE, Schaefer JR, Soufi M, Jacob S, Nitzgen U, Muller-Wieland D.

Atherosclerosis. 2011 Sep;218(1):134-43. doi: 10.1016/j.atherosclerosis.2011.05.008. Epub 2011 May 18.

PMID:
21645898
21.

Gender bias revisited: new insights on the differential management of chest pain.

Bösner S, Haasenritter J, Hani MA, Keller H, Sönnichsen AC, Karatolios K, Schaefer JR, Baum E, Donner-Banzhoff N.

BMC Fam Pract. 2011 Jun 6;12:45. doi: 10.1186/1471-2296-12-45.

22.

Lipid management for the prevention of cardiovascular disease.

Schaefer JR.

Curr Pharm Des. 2011;17(9):852-60. Review.

PMID:
21418030
23.

[New approaches to lecture medicine--or: what can we learn from television?].

Schaefer JR, Jerrentrup A, Neubauer A.

Dtsch Med Wochenschr. 2010 Dec;135(51-52):2596-600. doi: 10.1055/s-0030-1269432. Epub 2010 Dec 14. German.

PMID:
21157676
24.

Ruling out coronary artery disease in primary care: development and validation of a simple prediction rule.

Bösner S, Haasenritter J, Becker A, Karatolios K, Vaucher P, Gencer B, Herzig L, Heinzel-Gutenbrunner M, Schaefer JR, Abu Hani M, Keller H, Sönnichsen AC, Baum E, Donner-Banzhoff N.

CMAJ. 2010 Sep 7;182(12):1295-300. doi: 10.1503/cmaj.100212. Epub 2010 Jul 5.

25.

Accuracy of general practitioners' assessment of chest pain patients for coronary heart disease in primary care: cross-sectional study with follow-up.

Bösner S, Haasenritter J, Abu Hani M, Keller H, Sönnichsen AC, Karatolios K, Schaefer JR, Baum E, Donner-Banzhoff N.

Croat Med J. 2010 Jun;51(3):243-9.

26.

Accuracy of symptoms and signs for coronary heart disease assessed in primary care.

Bösner S, Becker A, Abu Hani M, Keller H, Sönnichsen AC, Haasenritter J, Karatolios K, Schaefer JR, Baum E, Donner-Banzhoff N.

Br J Gen Pract. 2010 Jun;60(575):e246-57. doi: 10.3399/bjgp10X502137.

27.

["Why is it always the heart which suffers from myocardial infarction?" The "Marburg hypothesis" of the pathogenesis of atherosclerosis].

Schaefer JR, Hufnagel B, Maisch B, Krieglstein J.

Herz. 2010 May;35(3):192-7. doi: 10.1007/s00059-010-3332-4. German.

PMID:
20467931
28.

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.

Huijgen R, Abbink EJ, Bruckert E, Stalenhoef AF, Imholz BP, Durrington PN, Trip MD, Eriksson M, Visseren FL, Schaefer JR, Kastelein JJ; Triple Study Group.

Clin Ther. 2010 Apr;32(4):615-25. doi: 10.1016/j.clinthera.2010.04.014.

PMID:
20435231
29.

Chest wall syndrome in primary care patients with chest pain: presentation, associated features and diagnosis.

Bösner S, Becker A, Hani MA, Keller H, Sönnichsen AC, Karatolios K, Schaefer JR, Haasenritter J, Baum E, Donner-Banzhoff N.

Fam Pract. 2010 Aug;27(4):363-9. doi: 10.1093/fampra/cmq024. Epub 2010 Apr 20.

PMID:
20406787
30.

Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.

Soufi M, Kurt B, Schweer H, Sattler AM, Klaus G, Zschocke J, Schaefer JR.

Atheroscler Suppl. 2009 Dec 29;10(5):5-11. doi: 10.1016/S1567-5688(09)71802-1.

PMID:
20129366
31.

Gender differences in presentation and diagnosis of chest pain in primary care.

Bösner S, Haasenritter J, Hani MA, Keller H, Sönnichsen AC, Karatolios K, Schaefer JR, Baum E, Donner-Banzhoff N.

BMC Fam Pract. 2009 Dec 14;10:79. doi: 10.1186/1471-2296-10-79.

32.

Heartburn or angina? Differentiating gastrointestinal disease in primary care patients presenting with chest pain: a cross sectional diagnostic study.

Bösner S, Haasenritter J, Becker A, Hani MA, Keller H, Sönnichsen AC, Karatolios K, Schaefer JR, Baum E, Donner-Banzhoff N.

Int Arch Med. 2009 Dec 12;2:40. doi: 10.1186/1755-7682-2-40.

33.

Chest pain in primary care: epidemiology and pre-work-up probabilities.

Bösner S, Becker A, Haasenritter J, Abu Hani M, Keller H, Sönnichsen AC, Karatolios K, Schaefer JR, Seitz G, Baum E, Donner-Banzhoff N.

Eur J Gen Pract. 2009;15(3):141-6. doi: 10.3109/13814780903329528.

PMID:
19883149
34.

Unraveling hyperlipidemia type III (dysbetalipoproteinemia), slowly.

Schaefer JR.

Eur J Hum Genet. 2009 May;17(5):541-2. doi: 10.1038/ejhg.2008.222. Epub 2008 Nov 26. No abstract available.

35.

Kinetic studies of atherogenic lipoproteins in hemodialysis patients: do they tell us more about their pathology?

Kronenberg F, Ikewaki K, Schaefer JR, König P, Dieplinger H.

Semin Dial. 2007 Nov-Dec;20(6):554-60. Review.

PMID:
17991204
36.

Periodontal microbiota in patients with coronary artery disease measured by real-time polymerase chain reaction: a case-control study.

Nonnenmacher C, Stelzel M, Susin C, Sattler AM, Schaefer JR, Maisch B, Mutters R, Flores-de-Jacoby L.

J Periodontol. 2007 Sep;78(9):1724-30.

PMID:
17760542
37.

Story omitted key fact.

Schaefer JR.

Minn Med. 2007 Feb;90(2):6. No abstract available.

PMID:
17390470
38.

In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients.

Frischmann ME, Kronenberg F, Trenkwalder E, Schaefer JR, Schweer H, Dieplinger B, Koenig P, Ikewaki K, Dieplinger H.

Kidney Int. 2007 May;71(10):1036-43. Epub 2007 Feb 14.

39.

Molecular basis of obesity and the risk for cardiovascular disease.

Soufi M, Sattler AM, Herzum M, Maisch B, Schaefer JR.

Herz. 2006 May;31(3):200-6. Review.

PMID:
16770555
40.

Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease.

Pilz S, Scharnagl H, Tiran B, Seelhorst U, Wellnitz B, Boehm BO, Schaefer JR, März W.

J Clin Endocrinol Metab. 2006 Jul;91(7):2542-7. Epub 2006 Apr 4.

PMID:
16595593
41.

Cardiotoxicity of 5-fluorouracil.

Alter P, Herzum M, Soufi M, Schaefer JR, Maisch B.

Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):1-5. Review.

PMID:
16529545
42.

Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis.

Schoppet M, Sattler AM, Schaefer JR, Hofbauer LC.

Atherosclerosis. 2006 Feb;184(2):446-7. Epub 2005 Dec 1. No abstract available.

PMID:
16325821
43.

The 103I variant of the melanocortin 4 receptor is associated with low serum triglyceride levels.

Brönner G, Sattler AM, Hinney A, Soufi M, Geller F, Schäfer H, Maisch B, Hebebrand J, Schaefer JR.

J Clin Endocrinol Metab. 2006 Feb;91(2):535-8. Epub 2005 Nov 8.

PMID:
16278267
44.

Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis.

Ikewaki K, Schaefer JR, Frischmann ME, Okubo K, Hosoya T, Mochizuki S, Dieplinger B, Trenkwalder E, Schweer H, Kronenberg F, Koenig P, Dieplinger H.

Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2615-22. Epub 2005 Sep 29.

PMID:
16195474
45.

Lipids and lipoproteins in women.

Sattler AM, Soufi M, Maisch B, Schaefer JR.

Herz. 2005 Aug;30(5):368-74; quiz 429-30. Review. English, German.

PMID:
16132239
46.

Why does atherosclerosis occur where it occurs?

Schaefer JR, Klumpp S, Maisch B, Krieglstein J.

Atherosclerosis. 2005 Jun;180(2):417-8. Epub 2005 Apr 26. No abstract available.

PMID:
15910870
47.

Unsaturated fatty acids isolated from human lipoproteins activate protein phosphatase type 2Cbeta and induce apoptosis in endothelial cells.

Hufnagel B, Dworak M, Soufi M, Mester Z, Zhu Y, Schaefer JR, Klumpp S, Krieglstein J.

Atherosclerosis. 2005 Jun;180(2):245-54. Epub 2005 Jan 26.

PMID:
15910849
48.

Coronary artery spasm induced by 5-fluorouracil.

Alter P, Herzum M, Schaefer JR, Maisch B.

Z Kardiol. 2005 Jan;94(1):33-7.

PMID:
15668828
49.

Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor.

Schaefer JR, Sattler AM, Hackler B, Kurt B, Hackler R, Maisch B, Soufi M.

Clin Chem. 2004 Nov;50(11):2214. No abstract available.

50.

Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.

Spiecker M, Darius H, Hankeln T, Soufi M, Sattler AM, Schaefer JR, Node K, Börgel J, Mügge A, Lindpaintner K, Huesing A, Maisch B, Zeldin DC, Liao JK.

Circulation. 2004 Oct 12;110(15):2132-6. Epub 2004 Oct 4.

Supplemental Content

Loading ...
Support Center